MatsukiyoCocokara & Co×COSMOS Pharmaceutical
Different ways of making money, on the same scale.
Same yardstick
| Metric | MatsukiyoCocokara & CoFY ending Mar 2026 | COSMOS PharmaceuticalFY ending May 2026 |
|---|---|---|
| Revenue | ¥1.12T | ¥1.1T |
| COGS ratio | 64.8% | 79.1% |
| Operating margin | 7.6% | 3.9% |
| Net margin | 5.0% | 2.9% |
| FCF margin | 4.7% | -1.1% |
Highlighted = best value for that metric
Compare industry percentiles by axis
Each row uses the same 0–100 scale. Dots show each company's rank within its primary industry.
- MatsukiyoCocokara & CoPrimary industry: Drugstores & Pharmacies
- COSMOS PharmaceuticalPrimary industry: Drugstores & Pharmacies
CompanyRank
Revenue growth
- MatsukiyoCocokara & Co90.616 peers
- COSMOS Pharmaceutical53.116 peers
- MatsukiyoCocokara & Co
Profitability
- MatsukiyoCocokara & Co97.419 peers
- COSMOS Pharmaceutical44.719 peers
- MatsukiyoCocokara & Co
Cash conversion
- MatsukiyoCocokara & Co30.618 peers
- COSMOS Pharmaceutical7518 peers
- MatsukiyoCocokara & Co
Efficiency
- MatsukiyoCocokara & Co28.919 peers
- COSMOS Pharmaceutical81.619 peers
- MatsukiyoCocokara & Co
Financial strength
- MatsukiyoCocokara & CoN/A
- COSMOS PharmaceuticalN/A
- MatsukiyoCocokara & Co
Each dot is a company's percentile within its primary industry; peer groups may differ. Missing axes are labeled as unavailable. No combined score is calculated, and industry rank is not an investment recommendation.
Money flows side by side
Chart height is proportional to revenue.
MatsukiyoCocokara & Co¥1.12T · keeps ¥7 per ¥100
COSMOS Pharmaceutical¥1.1T · keeps ¥4 per ¥100
Analyze this page with AI
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.